05/16/2019
3:24 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 |  |
05/01/2019
3:15 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2019
3:16 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/12/2019
4:27 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/03/2019
3:01 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2019
4:16 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/12/2019
4:19 PM | Ascendis Pharma A/S (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A
| |
03/08/2019
3:10 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2019
4:23 PM | Ascendis Pharma A/S (Filer)
| Form 424B5
| |
03/04/2019
3:39 PM | Ascendis Pharma A/S (Filer)
| Form 424B5
| |
03/04/2019
5:31 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/01/2019
8:01 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2019
12:51 PM | Ascendis Pharma A/S (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
| Form SC 13G
| |
02/14/2019
10:41 AM | Ascendis Pharma A/S (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A
| |
02/13/2019
3:29 PM | Ascendis Pharma A/S (Subject)
BAKER BROS. ADVISORS LP (Filed by)
| Form SC 13G/A
| |
02/13/2019
10:42 AM | Ascendis Pharma A/S (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
02/11/2019
3:51 PM | Ascendis Pharma A/S (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A
| |
02/11/2019
3:50 PM | Ascendis Pharma A/S (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A
| |
02/08/2019
4:22 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/08/2019
4:21 PM | Ascendis Pharma A/S (Filer)
| Form 424B5
| |
01/11/2019
2:54 PM | Ascendis Pharma A/S (Subject)
Sofinnova Venture Partners IX, L.P. (Filed by)
| Form SC 13D/A
| |
01/10/2019
4:20 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/07/2019
10:02 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/07/2019
8:06 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/04/2019
3:06 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/14/2018
3:13 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/07/2018
4:22 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/28/2018
3:13 PM | Ascendis Pharma A/S (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/28/2018
3:08 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/16/2018
3:39 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/08/2018
3:11 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/02/2018
4:01 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/12/2018
3:06 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/03/2018
3:04 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/02/2018
5:04 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/13/2018
3:07 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/12/2018
4:13 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/29/2018
3:44 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/17/2018
3:07 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/13/2018
3:02 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2018
3:07 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/29/2018
3:08 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/15/2018
3:06 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/15/2018
3:04 PM | Ascendis Pharma A/S (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A
| |
06/06/2018
4:25 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2018
3:05 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/30/2018
3:10 PM | Ascendis Pharma A/S (Filer)
| Form F-3ASR
| |
05/30/2018
3:05 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/09/2018
4:00 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/03/2018
2:08 PM | Ascendis Pharma A/S (Filer)
| Form CT ORDER
| |
05/01/2018
3:06 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/12/2018
4:12 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/28/2018
3:17 PM | Ascendis Pharma A/S (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/28/2018
3:07 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/15/2018
3:06 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/26/2018
3:07 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/21/2018
8:39 PM | Ascendis Pharma A/S (Filer)
| Form F-3MEF
| |
02/20/2018
4:16 PM | Ascendis Pharma A/S (Filer)
| Form 424B5
| |
02/20/2018
3:06 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/15/2018
4:04 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2018
1:50 PM | Ascendis Pharma A/S (Subject)
Sofinnova Capital V FCPR (Filed by)
| Form SC 13D/A
| |
02/13/2018
3:30 PM | Ascendis Pharma A/S (Subject)
BAKER BROS. ADVISORS LP (Filed by)
| Form SC 13G
| |
02/13/2018
8:49 AM | Ascendis Pharma A/S (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
01/29/2018
4:29 PM | Ascendis Pharma A/S (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A
| |
01/10/2018
3:13 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2018
7:02 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/03/2018
3:37 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/29/2017
3:19 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/29/2017
3:17 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2017
3:06 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/14/2017
3:07 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/28/2017
8:00 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
